92 related articles for article (PubMed ID: 8248641)
21. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
22. [Clinical efficacy and safety of sequential treatment with alprostadil and beraprost sodium for chronic renal failure induced by chronic glomerulonephritis].
Chen Y; Wan JX; Jiang DW; Fu BB; Cui J; Li GF
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1521-4. PubMed ID: 24144760
[TBL] [Abstract][Full Text] [Related]
23. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
24. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus.
Schiel R; Heinrich S; Steiner T; Ott U; Stein G
Nephrol Dial Transplant; 2005 Mar; 20(3):611-7. PubMed ID: 15689368
[TBL] [Abstract][Full Text] [Related]
25. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
26. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
27. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
Khajehdehi P; Roozbeh J; Mostafavi H
Scand J Urol Nephrol; 2002; 36(2):145-8. PubMed ID: 12028688
[TBL] [Abstract][Full Text] [Related]
28. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
29. Maintaining patency of tunneled hemodialysis catheters--efficacy of aspirin compared to warfarin.
Obialo CI; Conner AC; Lebon LF
Scand J Urol Nephrol; 2003; 37(2):172-6. PubMed ID: 12745728
[TBL] [Abstract][Full Text] [Related]
30. Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
Gordge MP; Rylance PB; Neild GH
Clin Nephrol; 1992 Jan; 37(1):53-5. PubMed ID: 1541067
[No Abstract] [Full Text] [Related]
31. [Renal graft survival in patients with systemic lupus erythematosus].
Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
[TBL] [Abstract][Full Text] [Related]
32. Laboratory signs of aspirin response in haemodialysis patients.
Kilickesmez KO; Kocas C; Okcun B; Abaci O; Kaya A; Arat A; Gorcin B; Gurmen T
Scand J Clin Lab Invest; 2011 Sep; 71(5):426-31. PubMed ID: 21554056
[TBL] [Abstract][Full Text] [Related]
33. Positive effects of protein restriction in patients with chronic kidney disease.
Eyre S; Attman PO; Haraldsson B
J Ren Nutr; 2008 May; 18(3):269-80. PubMed ID: 18410883
[TBL] [Abstract][Full Text] [Related]
34. IgA nephropathy: a long-term progressive study.
Orłowski T; Górski A; Rancewicz Z; Morzycka-Michalik M; Smogorzewski M; Małdyk M; Lao M; Szczesny-Nowicka B
Miner Electrolyte Metab; 1990; 16(1):54-6. PubMed ID: 2325593
[TBL] [Abstract][Full Text] [Related]
35. Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy.
Kincaid-Smith P; Laver MC; Fairley KF
Med J Aust; 1970 Jan; 1(4):145-51. PubMed ID: 4907738
[No Abstract] [Full Text] [Related]
36. [Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole].
Knotková V; Petrů I; Nĕmecek K; Cieslar P; Pelèska J; Jáchymová M; Pick P; Tomasy M
Cas Lek Cesk; 1989 Jun; 128(26):814-8. PubMed ID: 2507156
[TBL] [Abstract][Full Text] [Related]
37. Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: the effect of antiplatelet agents.
Cattell V; Mehotra A
Br J Exp Pathol; 1980 Jun; 61(3):310-4. PubMed ID: 7000132
[TBL] [Abstract][Full Text] [Related]
38. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
[TBL] [Abstract][Full Text] [Related]
39. [Hemodynamics of the lesser circulation and pulmonary ventilation in patients with chronic glomerulonephritis and chronic renal failure].
Bulychev AB; Pikulev LA
Klin Med (Mosk); 1991 Feb; 69(2):67-8. PubMed ID: 1875667
[TBL] [Abstract][Full Text] [Related]
40. [The efficacy of using antiaggregants in chronic glomerulonephritis with grade-I chronic kidney failure].
Kolesnyk MO; Lapchyns'ka II
Lik Sprava; 1996; (1-2):135-7. PubMed ID: 9005074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
